CLL Support Association

ACP-196 (Acalabrutinib) TRIAL - 31st monthly cycle achieved with full remission

Not been here for a while as nothing really to report. Husband is still on the ACP-196 trial and has just come up to his 31st monthly cycle. He had a bone marrow biopsy two weeks ago and went for his 3-monthly checkup last Monday. The good news is he is in full remission. At he moment he has been told he will probably be kept on the tablets indefinitely, but we will know more after the meeting with doctors and the pharmaceutical company in the next few months. Will let you know of the outcome of that soon. In the meantime we are just happy with the outcome of this trial and can't thank Professor Devereux and his team at Kings College Hospital enough.

Title enhanced and topic assigned - Admin

10 Replies
oldestnewest

Congrats on your husband's full remission! That's great news! How have side effects been for him? This is Acalabrutinib, right?

Reply

Yes it is. He has not really had any side effects from the drug at all. He had all the symptoms of CLL, e.g. tiredness, fatigue, aches and bruising, but they have gradually subsided over the 30 months of the trial. He still bruises easily but they are not worried about this as it is not a regular thing. It's been a long journey but we got there in the end.

6 likes
Reply

Fantastic! Acalabrutinib sounds like the one we've been waiting for. So happy for both of you that he has had this success!

3 likes
Reply

Fabulous news Babs!!!

🎉🎉🎉🎉🎉🎉🎉🎉

3 likes
Reply

Good news Babswade for you both.

Best wishes.

Sue

1 like
Reply

I am in the middle of cycle 33 of a phase 1, ACP-196 drug trial. My medical consent form for the trial only takes me through to cycle 36. When I visit MD Anderson this month, I will ask about post cycle 36. My expectations are that I will be kept on ACP-196 with dreaded CT scans every 6 months. I have not had any adverse side effects.

5 likes
Reply

Our contract only goes to 36 months as well but the docs seem to think the company will carry the tablets on with similar 6 month checkouts and scans. All worth it to keep the other half well. Hope you also continue to keep well.

2 likes
Reply

Wow. Great!

Reply

august 1 - FDA Grants Breakthrough Therapy Designation for Acalabrutinib. Not for CLL yet but maybe used off label

Reply

So happy for your husband.

1 like
Reply

You may also like...